Samsara Biocapital Gp, Llc - Net Worth and Insider Trading

Samsara Biocapital Gp, Llc Net Worth

The estimated net worth of Samsara Biocapital Gp, Llc is at least $236 Million dollars as of 2024-04-27. Samsara Biocapital Gp, Llc is the 10% Owner of Scholar Rock Holding Corp and owns about 6,788,609 shares of Scholar Rock Holding Corp (SRRK) stock worth over $99 Million. Samsara Biocapital Gp, Llc is the 10% Owner of Cargo Therapeutics Inc and owns about 4,121,689 shares of Cargo Therapeutics Inc (CRGX) stock worth over $77 Million. Samsara Biocapital Gp, Llc is also the 10% Owner of Mineralys Therapeutics Inc and owns about 5,074,916 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $60 Million. Details can be seen in Samsara Biocapital Gp, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Samsara Biocapital Gp, Llc has not made any transactions after 2024-02-12 and currently still holds the listed stock(s).

Transaction Summary of Samsara Biocapital Gp, Llc

To

Samsara Biocapital Gp, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samsara Biocapital Gp, Llc owns 1 companies in total, including Scholar Rock Holding Corp (SRRK) .

Click here to see the complete history of Samsara Biocapital Gp, Llc’s form 4 insider trades.

Insider Ownership Summary of Samsara Biocapital Gp, Llc

Ticker Comapny Transaction Date Type of Owner
SRRK Scholar Rock Holding Corp 2023-10-16 10 percent owner

Samsara Biocapital Gp, Llc Latest Holdings Summary

Samsara Biocapital Gp, Llc currently owns a total of 3 stocks. Among these stocks, Samsara Biocapital Gp, Llc owns 6,788,609 shares of Scholar Rock Holding Corp (SRRK) as of October 16, 2023, with a value of $99 Million and a weighting of 41.82%. Samsara Biocapital Gp, Llc owns 4,121,689 shares of Cargo Therapeutics Inc (CRGX) as of November 14, 2023, with a value of $77 Million and a weighting of 32.64%. Samsara Biocapital Gp, Llc also owns 5,074,916 shares of Mineralys Therapeutics Inc (MLYS) as of February 12, 2024, with a value of $60 Million and a weighting of 25.54%.

Latest Holdings of Samsara Biocapital Gp, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRRK Scholar Rock Holding Corp 2023-10-16 6,788,609 14.53 98,638,489
CRGX Cargo Therapeutics Inc 2023-11-14 4,121,689 18.68 76,993,151
MLYS Mineralys Therapeutics Inc 2024-02-12 5,074,916 11.87 60,239,253

Holding Weightings of Samsara Biocapital Gp, Llc


Samsara Biocapital Gp, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 2,189,781 shares on October 16, 2023, which cost Samsara Biocapital Gp, Llc around $15 Million.

According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Cargo Therapeutics Inc (CRGX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cargo Therapeutics Inc is the acquisition of 666,666 shares on November 14, 2023, which cost Samsara Biocapital Gp, Llc around $10 Million.

According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mineralys Therapeutics Inc is the acquisition of 555,555 shares on February 12, 2024, which cost Samsara Biocapital Gp, Llc around $7 Million.

Insider Trading History of Samsara Biocapital Gp, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samsara Biocapital Gp, Llc Trading Performance

GuruFocus tracks the stock performance after each of Samsara Biocapital Gp, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samsara Biocapital Gp, Llc is 69.53%. GuruFocus also compares Samsara Biocapital Gp, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samsara Biocapital Gp, Llc within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samsara Biocapital Gp, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samsara Biocapital Gp, Llc

Average Return

No transaction record over 1 year.

Outperforming Transactions

No transaction record over 1 year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.58 69.53 62.83
Relative Return to S&P 500(%) 8.87 59.43 45.69

Samsara Biocapital Gp, Llc Ownership Network

Ownership Network List of Samsara Biocapital Gp, Llc

No Data

Ownership Network Relation of Samsara Biocapital Gp, Llc


Samsara Biocapital Gp, Llc Owned Company Details

What does Scholar Rock Holding Corp do?

Who are the key executives at Scholar Rock Holding Corp?

Samsara Biocapital Gp, Llc is the 10 percent owner of Scholar Rock Holding Corp. Other key executives at Scholar Rock Holding Corp include SVP and Head of Research Mo Qatanani , CHRO Caryn Parlavecchio , and General Counsel Junlin Ho .

Scholar Rock Holding Corp (SRRK) Insider Trades Summary

Over the past 18 months, Samsara Biocapital Gp, Llc made 1 insider transaction in Scholar Rock Holding Corp (SRRK) with a net purchase of 2,189,781. Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 83,758 shares made by Edward H Myles , a net purchase of 2,279,168 shares made by Invus Public Equities, L.p. , and a net sale of 31,121 shares made by Mo Qatanani .

In summary, during the past 3 months, insiders sold 11,007 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 11,007 shares. During the past 18 months, 128,112 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,659,824 shares were bought by its insiders, resulting in a net purchase of 6,531,712 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Scholar Rock Holding Corp Insider Transactions

No Available Data

Samsara Biocapital Gp, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Samsara Biocapital Gp, Llc. You might contact Samsara Biocapital Gp, Llc via mailing address: 251 Churchill Avenue, Palo Alto Ca 94301.

Discussions on Samsara Biocapital Gp, Llc

No discussions yet.